Biotechnology
The Biotechnology industry has a total of 654 stocks, with a combined market cap of $764.25 billion and total revenue of $96.77 billion.
Market Cap
764.25B
Revenue
96.77B
Profits
-46.56B
PE Ratio
n/a
Profit Margin
-48.11%
Dividend Yield
0.05%
654 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.59B | 3.16% | 1,195,562 | 11.10B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 60.62B | 8.70% | 1,245,350 | 14.09B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.82B | 6.34% | 800,143 | 2.35B |
| 4 | ARGX | argenx SE | 33.86B | 2.08% | 476,771 | 2.64B |
| 5 | ONC | BeiGene, Ltd. | 25.10B | 0.23% | 370,396 | 4.18B |
| 6 | BNTX | BioNTech SE | 23.22B | 4.13% | 527,868 | 2.97B |
| 7 | RPRX | Royalty Pharma plc | 18.71B | 0.36% | 3,591,795 | 2.26B |
| 8 | SMMT | Summit Therapeutics Inc. | 18.34B | 3.05% | 2,061,596 | - |
| 9 | INSM | Insmed Incorporated | 12.36B | 4.30% | 2,023,434 | 381.03M |
| 10 | GMAB | Genmab A/S | 12.23B | 2.53% | 1,945,110 | 3.14B |
| 11 | BMRN | BioMarin Pharmaceutical Inc. | 11.79B | 4.43% | 799,128 | 2.95B |
| 12 | INCY | Incyte Corporation | 11.77B | 3.05% | 862,835 | 4.41B |
| 13 | EXEL | Exelixis, Inc. | 10.22B | 2.52% | 1,502,950 | 2.17B |
| 14 | MRNA | Moderna, Inc. | 9.94B | 5.94% | 8,882,852 | 3.18B |
| 15 | ASND | Ascendis Pharma A/S | 9.44B | 3.40% | 236,442 | 398.51M |
| 16 | TECH | Bio-Techne Corporation | 8.40B | 7.34% | 2,132,329 | 1.21B |
| 17 | HALO | Halozyme Therapeutics, Inc. | 8.16B | 0.50% | 1,790,483 | 1.08B |
| 18 | ROIV | Roivant Sciences Ltd. | 7.85B | 3.43% | 2,666,346 | 122.59M |
| 19 | RVMD | Revolution Medicines, Inc. | 7.80B | 3.61% | 723,674 | - |
| 20 | CORT | Corcept Therapeutics Incorporated | 7.63B | 2.51% | 695,222 | 685.45M |
| 21 | BBIO | BridgeBio Pharma, Inc. | 6.79B | 4.65% | 1,367,342 | 127.42M |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.69B | 2.24% | 163,842 | 317.38M |
| 23 | BPMC | Blueprint Medicines Corporation | 6.45B | 2.81% | 419,302 | 562.12M |
| 24 | JAZZ | Jazz Pharmaceuticals plc | 6.40B | 6.21% | 943,943 | 4.06B |
| 25 | VRNA | Verona Pharma plc | 6.20B | 7.39% | 943,489 | 118.54M |
| 26 | LEGN | Legend Biotech Corporation | 6.00B | 2.77% | 888,560 | 627.24M |
| 27 | AXSM | Axsome Therapeutics, Inc. | 5.42B | 2.17% | 327,870 | 432.16M |
| 28 | IONS | Ionis Pharmaceuticals, Inc. | 5.34B | 3.94% | 611,386 | 717.25M |
| 29 | NUVL | Nuvalent, Inc. | 5.31B | 5.88% | 285,528 | - |
| 30 | TLX | Telix Pharmaceuticals Limited | 5.31B | -5.88% | 30,328 | 484.69M |
| 31 | TGTX | TG Therapeutics, Inc. | 5.09B | 3.80% | 1,747,252 | 386.39M |
| 32 | ADMA | ADMA Biologics, Inc. | 4.90B | 2.70% | 2,957,506 | 459.38M |
| 33 | PCVX | Vaxcyte, Inc. | 4.10B | 1.99% | 1,337,594 | - |
| 34 | KRYS | Krystal Biotech, Inc. | 4.02B | 5.16% | 168,464 | 333.45M |
| 35 | SLNO | Soleno Therapeutics, Inc. | 3.92B | 1.39% | 322,199 | - |
| 36 | CYTK | Cytokinetics, Incorporated | 3.85B | 1.69% | 1,259,864 | 19.22M |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.76B | 3.03% | 256,837 | 136.86M |
| 38 | PTCT | PTC Therapeutics, Inc. | 3.63B | 3.64% | 845,780 | 1.77B |
| 39 | SRPT | Sarepta Therapeutics, Inc. | 3.61B | 1.16% | 3,954,551 | 2.23B |
| 40 | RNA | Avidity Biosciences, Inc. | 3.53B | 5.13% | 673,575 | 8.93M |
| 41 | SWTX | SpringWorks Therapeutics, Inc. | 3.47B | -0.30% | 6,315,230 | 219.67M |
| 42 | RARE | Ultragenyx Pharmaceutical Inc. | 3.45B | 4.04% | 596,598 | 590.69M |
| 43 | ACLX | Arcellx, Inc. | 3.33B | 5.06% | 323,906 | 76.81M |
| 44 | AKRO | Akero Therapeutics, Inc. | 3.33B | 4.79% | 1,017,276 | - |
| 45 | CRSP | CRISPR Therapeutics AG | 3.25B | 5.73% | 1,204,230 | 37.68M |
| 46 | ZLAB | Zai Lab Limited | 3.23B | 0.51% | 534,928 | 418.33M |
| 47 | VKTX | Viking Therapeutics, Inc. | 3.21B | 3.74% | 2,635,400 | - |
| 48 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.11B | 8.12% | 699,972 | 760.00K |
| 49 | SRRK | Scholar Rock Holding Corporation | 3.08B | 5.84% | 530,337 | - |
| 50 | MRUS | Merus N.V. | 2.94B | 3.94% | 458,800 | 54.73M |
| 51 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.92B | 2.57% | 658,151 | 534.65M |
| 52 | ACAD | ACADIA Pharmaceuticals Inc. | 2.91B | -0.40% | 1,531,837 | 996.28M |
| 53 | MTSR | Metsera, Inc. | 2.80B | 11.54% | 390,414 | - |
| 54 | PTGX | Protagonist Therapeutics, Inc. | 2.79B | 4.93% | 538,433 | 207.80M |
| 55 | XENE | Xenon Pharmaceuticals Inc. | 2.74B | 2.31% | 558,982 | - |
| 56 | MLTX | MoonLake Immunotherapeutics | 2.54B | 4.47% | 122,999 | - |
| 57 | IMVT | Immunovant, Inc. | 2.46B | 3.28% | 540,946 | - |
| 58 | APGE | Apogee Therapeutics, Inc. | 2.28B | 6.78% | 414,040 | - |
| 59 | MIRM | Mirum Pharmaceuticals, Inc. | 2.28B | 3.77% | 188,278 | 379.25M |
| 60 | APLS | Apellis Pharmaceuticals, Inc. | 2.20B | 0.98% | 1,748,563 | 775.84M |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 2.15B | 4.46% | 320,336 | 47.14M |
| 62 | DNLI | Denali Therapeutics Inc. | 2.13B | 2.23% | 902,055 | - |
| 63 | VCEL | Vericel Corporation | 2.13B | 1.34% | 305,870 | 238.54M |
| 64 | KYMR | Kymera Therapeutics, Inc. | 2.12B | 8.05% | 379,019 | 58.89M |
| 65 | BHVN | Biohaven Ltd. | 2.08B | 0.64% | 726,705 | - |
| 66 | IBRX | ImmunityBio, Inc. | 2.08B | 13.77% | 9,450,595 | 31.22M |
| 67 | LGND | Ligand Pharmaceuticals Incorporated | 2.05B | 1.80% | 63,460 | 181.49M |
| 68 | HRMY | Harmony Biosciences Holdings, Inc. | 2.03B | 3.82% | 564,684 | 744.85M |
| 69 | BLTE | Belite Bio, Inc | 2.00B | 1.31% | 8,525 | - |
| 70 | AAPG | Ascentage Pharma Group International | 1.99B | -0.08% | 10,706 | 134.35M |
| 71 | CGON | CG Oncology, Inc. | 1.94B | 6.99% | 606,076 | 1.14M |
| 72 | FOLD | Amicus Therapeutics, Inc. | 1.92B | 4.01% | 4,234,710 | 543.14M |
| 73 | TVTX | Travere Therapeutics, Inc. | 1.91B | 7.64% | 696,222 | 273.53M |
| 74 | TARS | Tarsus Pharmaceuticals, Inc. | 1.88B | -0.16% | 405,437 | 233.67M |
| 75 | RXRX | Recursion Pharmaceuticals, Inc. | 1.87B | 6.35% | 19,706,193 | 59.79M |
| 76 | BEAM | Beam Therapeutics Inc. | 1.78B | 4.77% | 1,152,957 | 63.58M |
| 77 | CNTA | Centessa Pharmaceuticals plc | 1.76B | 7.56% | 205,836 | - |
| 78 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.75B | 6.68% | 1,048,989 | 2.50M |
| 79 | ARQT | Arcutis Biotherapeutics, Inc. | 1.72B | 6.36% | 1,527,901 | 212.82M |
| 80 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | 6.84% | 249,616 | 37.04M |
| 81 | GLPG | Galapagos NV | 1.69B | -0.65% | 252,138 | 311.49M |
| 82 | IRON | Disc Medicine, Inc. | 1.62B | 5.81% | 250,900 | - |
| 83 | IDYA | IDEAYA Biosciences, Inc. | 1.61B | 5.40% | 657,820 | 7.00M |
| 84 | EWTX | Edgewise Therapeutics, Inc. | 1.58B | 3.22% | 664,349 | - |
| 85 | JANX | Janux Therapeutics, Inc. | 1.54B | 1.76% | 989,001 | 9.34M |
| 86 | IMCR | Immunocore Holdings plc | 1.46B | 2.92% | 205,576 | 333.58M |
| 87 | MNKD | MannKind Corporation | 1.46B | 5.26% | 1,618,365 | 297.60M |
| 88 | ADPT | Adaptive Biotechnologies Corporation | 1.45B | 5.87% | 1,023,217 | 189.53M |
| 89 | VERA | Vera Therapeutics, Inc. | 1.45B | 4.84% | 300,915 | - |
| 90 | DYN | Dyne Therapeutics, Inc. | 1.43B | 10.17% | 2,930,985 | - |
| 91 | GPCR | Structure Therapeutics Inc. | 1.42B | -3.21% | 350,242 | - |
| 92 | MESO | Mesoblast Limited | 1.41B | 3.37% | 66,217 | 5.67M |
| 93 | LQDA | Liquidia Corporation | 1.38B | 5.57% | 647,433 | 14.14M |
| 94 | CLDX | Celldex Therapeutics, Inc. | 1.32B | 8.59% | 395,501 | 7.56M |
| 95 | SPRY | ARS Pharmaceuticals, Inc. | 1.32B | -0.04% | 1,151,900 | 89.15M |
| 96 | ETNB | 89bio, Inc. | 1.18B | 5.19% | 863,063 | - |
| 97 | INVA | Innoviva, Inc. | 1.17B | 0.48% | 187,326 | 369.84M |
| 98 | OCUL | Ocular Therapeutix, Inc. | 1.17B | 3.68% | 795,691 | 59.65M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.12B | 2.00% | 1,287,752 | 247.30M |
| 100 | VRDN | Viridian Therapeutics, Inc. | 1.07B | 5.57% | 519,934 | 302.00K |
| 101 | MDXG | MiMedx Group, Inc. | 1.06B | 2.13% | 479,976 | 352.38M |
| 102 | NVAX | Novavax, Inc. | 1.04B | 7.45% | 7,784,351 | 1.25B |
| 103 | WVE | Wave Life Sciences Ltd. | 1.02B | 0.99% | 752,042 | 104.94M |
| 104 | MLYS | Mineralys Therapeutics, Inc. | 982.87M | 3.41% | 476,088 | - |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 951.68M | 3.36% | 874,800 | 43.72M |
| 106 | GYRE | Gyre Therapeutics, Inc. | 947.97M | 12.91% | 81,724 | 100.64M |
| 107 | OCS | Oculis Holding AG | 944.60M | -3.97% | 25,357 | 847.33K |
| 108 | ELVN | Enliven Therapeutics, Inc. | 942.07M | 4.23% | 221,838 | - |
| 109 | RCUS | Arcus Biosciences, Inc. | 941.32M | 7.37% | 1,883,853 | 141.00M |
| 110 | SYRE | Spyre Therapeutics, Inc. | 917.37M | 7.80% | 245,044 | - |
| 111 | PHVS | Pharvaris N.V. | 908.13M | -1.91% | 8,625 | - |
| 112 | NTLA | Intellia Therapeutics, Inc. | 889.78M | 5.79% | 2,641,202 | 45.57M |
| 113 | ZYME | Zymeworks Inc. | 841.08M | 6.77% | 239,438 | 93.38M |
| 114 | ARDX | Ardelyx, Inc. | 839.79M | -3.04% | 4,190,417 | 361.71M |
| 115 | LENZ | LENZ Therapeutics, Inc. | 827.50M | 11.62% | 108,433 | - |
| 116 | GERN | Geron Corporation | 815.25M | 8.47% | 8,912,921 | 116.29M |
| 117 | CVAC | CureVac N.V. | 798.18M | 2.16% | 476,510 | 554.07M |
| 118 | XERS | Xeris Biopharma Holdings, Inc. | 789.56M | -1.60% | 2,094,418 | 222.55M |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 782.68M | 0.20% | 149,247 | 8.12M |
| 120 | CRMD | CorMedix Inc. | 776.59M | -1.80% | 957,480 | 82.55M |
| 121 | NRIX | Nurix Therapeutics, Inc. | 773.03M | 6.74% | 463,899 | 56.42M |
| 122 | RCKT | Rocket Pharmaceuticals, Inc. | 771.40M | 2.43% | 1,698,560 | - |
| 123 | BCAX | Bicara Therapeutics Inc. | 766.51M | 8.37% | 411,236 | - |
| 124 | NAGE | Niagen Bioscience, Inc. | 745.95M | 5.59% | 1,017,407 | 107.93M |
| 125 | VIR | Vir Biotechnology, Inc. | 733.35M | 4.33% | 1,379,966 | 20.86M |
| 126 | AVXL | Anavex Life Sciences Corp. | 725.66M | 3.03% | 421,644 | - |
| 127 | NUVB | Nuvation Bio Inc. | 717.95M | 0.96% | 2,252,253 | 10.96M |
| 128 | QURE | uniQure N.V. | 712.02M | 1.72% | 1,305,641 | 20.20M |
| 129 | IMNM | Immunome, Inc. | 691.31M | 6.50% | 541,084 | 9.04M |
| 130 | TRVI | Trevi Therapeutics, Inc. | 677.62M | 0.91% | 676,575 | - |
| 131 | DAWN | Day One Biopharmaceuticals, Inc. | 666.97M | 2.02% | 742,176 | 161.92M |
| 132 | PHAR | Pharming Group N.V. | 663.55M | -3.19% | 926 | 320.71M |
| 133 | AVBP | ArriVent BioPharma, Inc. | 660.82M | -3.67% | 110,572 | - |
| 134 | GHRS | GH Research PLC | 652.54M | 1.35% | 49,610 | - |
| 135 | DNTH | Dianthus Therapeutics, Inc. | 652.16M | 3.62% | 83,427 | 6.24M |
| 136 | IOVA | Iovance Biotherapeutics, Inc. | 639.48M | 9.43% | 28,160,897 | 212.68M |
| 137 | ABUS | Arbutus Biopharma Corporation | 637.63M | 3.10% | 487,217 | 6.17M |
| 138 | XNCR | Xencor, Inc. | 632.00M | 6.60% | 404,354 | 127.23M |
| 139 | SVRA | Savara Inc. | 629.66M | 4.55% | 999,339 | - |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 615.98M | 4.12% | 231,024 | - |
| 141 | ABCL | AbCellera Biologics Inc. | 613.85M | 1.48% | 3,316,538 | 23.11M |
| 142 | REPL | Replimune Group, Inc. | 608.42M | 2.46% | 367,488 | - |
| 143 | BCYC | Bicycle Therapeutics plc | 593.51M | 2.76% | 207,752 | 25.72M |
| 144 | COGT | Cogent Biosciences, Inc. | 590.18M | 7.69% | 384,035 | - |
| 145 | ANAB | AnaptysBio, Inc. | 589.08M | 2.35% | 231,294 | 111.87M |
| 146 | SION | Sionna Therapeutics, Inc. | 573.18M | 5.44% | 86,364 | - |
| 147 | KROS | Keros Therapeutics, Inc. | 565.77M | 2.05% | 941,165 | 214.71M |
| 148 | TYRA | Tyra Biosciences, Inc. | 557.84M | 3.96% | 108,415 | - |
| 149 | IMTX | Immatics N.V. | 553.05M | 7.31% | 473,073 | 161.34M |
| 150 | RLAY | Relay Therapeutics, Inc. | 545.19M | 6.00% | 1,050,911 | 7.68M |
| 151 | RGLS | Regulus Therapeutics Inc. | 544.53M | -0.06% | 707,990 | - |
| 152 | MRVI | Maravai LifeSciences Holdings, Inc. | 534.75M | 6.06% | 1,988,374 | 259.19M |
| 153 | KURA | Kura Oncology, Inc. | 534.17M | 7.12% | 508,182 | 67.99M |
| 154 | VALN | Valneva SE | 532.93M | 1.24% | 21,547 | 201.10M |
| 155 | STOK | Stoke Therapeutics, Inc. | 532.87M | 4.27% | 397,213 | 36.56M |
| 156 | UPB | Upstream Bio, Inc. | 516.42M | 8.84% | 90,493 | 2.30M |
| 157 | URGN | UroGen Pharma Ltd. | 513.03M | 7.23% | 692,832 | 91.87M |
| 158 | MNMD | Mind Medicine (MindMed) Inc. | 487.70M | 4.96% | 453,482 | - |
| 159 | ARVN | Arvinas, Inc. | 486.85M | 0.91% | 1,444,785 | 426.90M |
| 160 | SANA | Sana Biotechnology, Inc. | 486.07M | 18.41% | 6,067,724 | - |
| 161 | DNA | Ginkgo Bioworks Holdings, Inc. | 481.72M | 6.06% | 735,214 | 237.42M |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 467.99M | 5.17% | 361,976 | - |
| 163 | OPT | Opthea Limited | 466.57M | 1.49% | 3,025 | 208.86K |
| 164 | FTRE | Fortrea Holdings Inc. | 459.04M | -17.56% | 5,341,524 | 2.69B |
| 165 | ALT | Altimmune, Inc. | 456.69M | 6.08% | 1,866,291 | 20.00K |
| 166 | TSHA | Taysha Gene Therapies, Inc. | 455.22M | 4.23% | 1,927,073 | 8.33M |
| 167 | MGTX | MeiraGTx Holdings plc | 448.93M | 3.60% | 289,724 | 33.28M |
| 168 | TBPH | Theravance Biopharma, Inc. | 447.00M | -0.45% | 206,330 | 65.27M |
| 169 | MAZE | Maze Therapeutics, Inc. | 444.75M | 5.56% | 63,095 | 167.50M |
| 170 | ZVRA | Zevra Therapeutics, Inc. | 423.77M | -1.52% | 309,875 | 23.61M |
| 171 | SAGE | Sage Therapeutics, Inc. | 423.32M | 3.05% | 376,025 | 47.40M |
| 172 | AMLX | Amylyx Pharmaceuticals, Inc. | 414.22M | 1.41% | 806,361 | -1.27M |
| 173 | ZBIO | Zenas BioPharma, Inc. | 412.28M | 8.90% | 93,070 | 5.00M |
| 174 | TRML | Tourmaline Bio, Inc. | 411.02M | 5.96% | 66,214 | - |
| 175 | PRTA | Prothena Corporation plc | 407.47M | 1.88% | 825,943 | 137.94M |
| 176 | PGEN | Precigen, Inc. | 404.31M | 3.38% | 2,186,135 | 3.93M |
| 177 | EYPT | EyePoint Pharmaceuticals, Inc. | 403.24M | 0.86% | 324,225 | 56.04M |
| 178 | CELC | Celcuity Inc. | 401.10M | 4.43% | 90,571 | - |
| 179 | RGNX | REGENXBIO Inc. | 400.94M | 6.38% | 603,380 | 83.33M |
| 180 | PRTC | PureTech Health plc | 399.87M | -0.30% | 192 | 4.83M |
| 181 | ABVX | ABIVAX Société Anonyme | 397.77M | -3.50% | 69,637 | 11.17M |
| 182 | MREO | Mereo BioPharma Group plc | 397.50M | 3.73% | 944,344 | 1.00M |
| 183 | ERAS | Erasca, Inc. | 389.49M | -1.08% | 535,600 | - |
| 184 | RAPP | Rapport Therapeutics, Inc. | 388.70M | 3.90% | 52,767 | - |
| 185 | TECX | Tectonic Therapeutic, Inc. | 384.08M | 4.15% | 54,544 | - |
| 186 | ORIC | ORIC Pharmaceuticals, Inc. | 383.88M | 6.30% | 206,747 | - |
| 187 | VERV | Verve Therapeutics, Inc. | 377.08M | - | 1,945,177 | 32.33M |
| 188 | ABSI | Absci Corporation | 374.99M | 6.91% | 2,230,959 | 4.53M |
| 189 | MBX | MBX Biosciences, Inc. | 374.69M | 0.90% | 85,495 | - |
| 190 | AUTL | Autolus Therapeutics plc | 368.59M | 4.92% | 2,039,598 | 9.01M |
| 191 | VSTM | Verastem, Inc. | 365.58M | -0.98% | 1,652,060 | 10.00M |
| 192 | ORKA | Oruka Therapeutics, Inc. | 363.92M | 1.89% | 74,674 | - |
| 193 | CKPT | Checkpoint Therapeutics, Inc. | 348.46M | -0.24% | 297,470 | 41.00K |
| 194 | IVA | Inventiva S.A. | 344.88M | -3.31% | 3,470 | 14.59M |
| 195 | BNTC | Benitec Biopharma Inc. | 338.57M | -2.57% | 29,385 | - |
| 196 | RIGL | Rigel Pharmaceuticals, Inc. | 330.28M | -1.55% | 128,717 | 203.08M |
| 197 | OLMA | Olema Pharmaceuticals, Inc. | 326.76M | 3.91% | 365,447 | - |
| 198 | CAPR | Capricor Therapeutics, Inc. | 324.31M | 11.99% | 2,640,766 | 22.27M |
| 199 | HRTX | Heron Therapeutics, Inc. | 315.81M | -1.90% | 2,027,046 | 148.52M |
| 200 | ARCT | Arcturus Therapeutics Holdings Inc. | 313.78M | 5.37% | 235,674 | 152.31M |
| 201 | TRDA | Entrada Therapeutics, Inc. | 313.43M | 6.09% | 86,562 | 172.22M |
| 202 | SEPN | Septerna, Inc. | 313.39M | 5.23% | 127,019 | 1.08M |
| 203 | FULC | Fulcrum Therapeutics, Inc. | 308.76M | 6.52% | 366,305 | 80.00M |
| 204 | XOMA | XOMA Royalty Corporation | 299.00M | 3.41% | 6,145 | 28.49M |
| 205 | NNNN | Anbio Biotechnology | 295.83M | 4.82% | 41,776 | 8.19M |
| 206 | ATYR | aTyr Pharma, Inc. | 286.12M | -1.83% | 911,218 | 235.00K |
| 207 | ATAI | Atai Life Sciences N.V. | 285.71M | 2.88% | 1,045,366 | 308.00K |
| 208 | ALMS | Alumis Inc. | 285.64M | 4.37% | 207,538 | - |
| 209 | ABEO | Abeona Therapeutics Inc. | 276.64M | 8.16% | 2,924,991 | - |
| 210 | CMPX | Compass Therapeutics, Inc. | 276.56M | 9.89% | 918,093 | 850.00K |
| 211 | DBVT | DBV Technologies S.A. | 275.41M | 4.88% | 136,137 | 3.50M |
| 212 | CRVS | Corvus Pharmaceuticals, Inc. | 273.22M | -9.48% | 2,135,560 | - |
| 213 | IMMP | Immutep Limited | 269.98M | - | 189,893 | 3.02M |
| 214 | ITOS | iTeos Therapeutics, Inc. | 269.45M | 5.63% | 833,683 | 35.00M |
| 215 | RNAC | Cartesian Therapeutics, Inc. | 268.89M | 4.65% | 57,666 | 34.17M |
| 216 | AURA | Aura Biosciences, Inc. | 267.93M | 1.91% | 111,093 | - |
| 217 | TSVT | 2seventy bio, Inc. | 266.15M | 0.20% | 825,682 | 48.37M |
| 218 | GLUE | Monte Rosa Therapeutics, Inc. | 263.88M | 4.89% | 219,878 | 159.49M |
| 219 | TERN | Terns Pharmaceuticals, Inc. | 263.76M | -0.66% | 577,626 | - |
| 220 | JBIO | Jade Biosciences, Inc. | 260.44M | -4.16% | 92,136 | - |
| 221 | ALLO | Allogene Therapeutics, Inc. | 258.07M | 1.72% | 2,766,422 | 22.00K |
| 222 | AVIR | Atea Pharmaceuticals, Inc. | 255.88M | 9.93% | 584,314 | - |
| 223 | ATXS | Astria Therapeutics, Inc. | 252.26M | 5.67% | 449,356 | - |
| 224 | CADL | Candel Therapeutics, Inc. | 251.28M | 6.03% | 532,688 | - |
| 225 | GOSS | Gossamer Bio, Inc. | 251.08M | -0.45% | 780,562 | 114.70M |
| 226 | SLRN | Acelyrin, Inc. | 250.77M | 5.51% | 550,337 | - |
| 227 | CELZ | Creative Medical Technology Holdings, Inc. | 249.84M | -0.50% | 24,711 | 14.00K |
| 228 | NGNE | Neurogene Inc. | 249.02M | 18.53% | 240,674 | 925.00K |
| 229 | FHTX | Foghorn Therapeutics Inc. | 248.59M | 6.43% | 61,607 | 22.60M |
| 230 | LXRX | Lexicon Pharmaceuticals, Inc. | 244.26M | -3.42% | 4,077,058 | 31.08M |
| 231 | TVRD | Tvardi Therapeutics, Inc. | 243.81M | 1.76% | 15,367 | - |
| 232 | VNDA | Vanda Pharmaceuticals Inc. | 239.27M | 2.78% | 491,568 | 201.35M |
| 233 | DRTS | Alpha Tau Medical Ltd. | 239.11M | -4.07% | 68,544 | - |
| 234 | AARD | Aardvark Therapeutics, Inc. | 235.40M | 4.13% | 9,596 | - |
| 235 | OMER | Omeros Corporation | 234.58M | -34.63% | 5,011,781 | - |
| 236 | THRD | Third Harmonic Bio, Inc. | 233.54M | 0.49% | 174,406 | - |
| 237 | DRUG | Bright Minds Biosciences Inc. | 228.60M | 3.03% | 22,491 | - |
| 238 | PVLA | Palvella Therapeutics, Inc. | 227.65M | -9.27% | 36,679 | - |
| 239 | SLDB | Solid Biosciences Inc. | 225.53M | 5.43% | 944,586 | - |
| 240 | RZLT | Rezolute, Inc. | 224.59M | 0.27% | 327,230 | - |
| 241 | PROK | ProKidney Corp. | 221.31M | 4.81% | 423,301 | 76.00K |
| 242 | TVGN | Tevogen Bio Holdings Inc. | 220.67M | 10.09% | 997,151 | - |
| 243 | GNFT | Genfit S.A. | 219.10M | -0.70% | 21,963 | 73.19M |
| 244 | CDXS | Codexis, Inc. | 216.64M | 6.30% | 297,644 | 59.35M |
| 245 | KOD | Kodiak Sciences Inc. | 215.04M | 8.36% | 177,201 | - |
| 246 | MNPR | Monopar Therapeutics Inc. | 214.47M | -10.99% | 15,424 | - |
| 247 | CDTX | Cidara Therapeutics, Inc. | 213.59M | 4.67% | 129,538 | 302.00K |
| 248 | IPHA | Innate Pharma S.A. | 212.33M | -6.09% | 17,536 | 20.83M |
| 249 | PHAT | Phathom Pharmaceuticals, Inc. | 207.90M | -4.94% | 2,211,241 | 81.86M |
| 250 | TENX | Tenax Therapeutics, Inc. | 205.44M | 2.87% | 4,288 | - |
| 251 | DSGN | Design Therapeutics, Inc. | 204.93M | 3.14% | 28,163 | - |
| 252 | ACTU | Actuate Therapeutics, Inc. | 204.11M | 0.97% | 20,336 | - |
| 253 | HUMA | Humacyte, Inc. | 203.98M | 10.50% | 2,857,030 | - |
| 254 | MDWD | MediWound Ltd. | 202.64M | 6.99% | 99,058 | 20.22M |
| 255 | OCGN | Ocugen, Inc. | 201.79M | 3.13% | 2,435,296 | 4.52M |
| 256 | NVCT | Nuvectis Pharma, Inc. | 193.33M | -8.06% | 137,123 | - |
| 257 | ANNX | Annexon, Inc. | 189.81M | 8.12% | 1,247,321 | - |
| 258 | VYGR | Voyager Therapeutics, Inc. | 188.70M | 7.57% | 323,159 | 66.96M |
| 259 | CRGX | CARGO Therapeutics, Inc. | 188.60M | 1.74% | 305,166 | - |
| 260 | LIMN | Liminatus Pharma, Inc. | 186.52M | -3.76% | 58,867 | - |
| 261 | SLN | Silence Therapeutics plc | 183.70M | 5.14% | 70,631 | 27.70M |
| 262 | CRDF | Cardiff Oncology, Inc. | 183.61M | 3.76% | 587,838 | 587.00K |
| 263 | YMAB | Y-mAbs Therapeutics, Inc. | 183.59M | 4.37% | 68,624 | 87.69M |
| 264 | OABI | OmniAb, Inc. | 178.61M | 1.39% | 480,156 | 26.74M |
| 265 | ELDN | Eledon Pharmaceuticals, Inc. | 176.65M | 2.08% | 131,292 | - |
| 266 | PRME | Prime Medicine, Inc. | 175.76M | 5.77% | 1,109,963 | 3.85M |
| 267 | FENC | Fennec Pharmaceuticals Inc. | 173.84M | 5.88% | 49,990 | 47.54M |
| 268 | INMB | INmune Bio, Inc. | 172.34M | 6.53% | 209,107 | 50.00K |
| 269 | INBX | Inhibrx Biosciences, Inc. | 170.82M | 5.59% | 33,315 | 200.00K |
| 270 | PRQR | ProQR Therapeutics N.V. | 170.44M | 0.62% | 255,751 | 21.21M |
| 271 | HURA | TuHURA Biosciences, Inc. | 167.30M | -4.01% | 57,125 | - |
| 272 | SGMO | Sangamo Therapeutics, Inc. | 165.03M | 4.88% | 2,617,134 | 57.80M |
| 273 | DMAC | DiaMedica Therapeutics Inc. | 164.57M | 4.92% | 69,951 | - |
| 274 | NBTX | Nanobiotix S.A. | 163.94M | -0.52% | 1,325 | -7.44M |
| 275 | TLSA | Tiziana Life Sciences Ltd | 163.63M | -4.46% | 380,694 | - |
| 276 | ACIU | AC Immune SA | 161.28M | -2.98% | 173,137 | 32.01M |
| 277 | IKT | Inhibikase Therapeutics, Inc. | 159.83M | 7.50% | 111,684 | 1.00 |
| 278 | CTMX | CytomX Therapeutics, Inc. | 157.21M | 110.04% | 97,886,173 | 147.56M |
| 279 | FDMT | 4D Molecular Therapeutics, Inc. | 154.72M | 8.44% | 312,741 | 23.00K |
| 280 | MOLN | Molecular Partners AG | 152.91M | -0.49% | 1,172 | 5.48M |
| 281 | ENGNW | enGene Holdings Inc. | 150.89M | 2.88% | 2,260 | - |
| 282 | PBYI | Puma Biotechnology, Inc. | 150.65M | 4.30% | 332,089 | 232.71M |
| 283 | KRRO | Korro Bio, Inc. | 150.34M | 2.89% | 33,215 | 4.82M |
| 284 | ENGN | enGene Holdings Inc. | 145.29M | -3.72% | 150,355 | - |
| 285 | NKTX | Nkarta, Inc. | 142.62M | 4.15% | 377,916 | - |
| 286 | CYBN | Cybin Inc. | 141.47M | -4.61% | 148,994 | - |
| 287 | EPRX | Eupraxia Pharmaceuticals Inc. | 138.87M | 1.32% | 1,218 | - |
| 288 | ACRS | Aclaris Therapeutics, Inc. | 138.06M | 1.19% | 308,635 | 17.78M |
| 289 | TNGX | Tango Therapeutics, Inc. | 137.30M | 11.40% | 677,821 | 40.99M |
| 290 | SLS | SELLAS Life Sciences Group, Inc. | 137.18M | -3.21% | 1,408,340 | - |
| 291 | ALDX | Aldeyra Therapeutics, Inc. | 135.36M | 3.67% | 729,003 | - |
| 292 | LRMR | Larimar Therapeutics, Inc. | 133.18M | -1.89% | 1,055,659 | - |
| 293 | NKTR | Nektar Therapeutics | 131.89M | 20.38% | 2,698,542 | 87.25M |
| 294 | ADCT | ADC Therapeutics SA | 128.93M | 2.36% | 153,572 | 70.84M |
| 295 | GLSI | Greenwich LifeSciences, Inc. | 127.00M | 1.46% | 12,640 | - |
| 296 | NTHI | NeOnc Technologies Holdings, Inc. | 126.53M | -8.04% | 127,602 | 79.99K |
| 297 | LYEL | Lyell Immunopharma, Inc. | 126.29M | 6.90% | 575,732 | 61.00K |
| 298 | CGEN | Compugen Ltd. | 125.31M | 6.35% | 165,846 | 27.86M |
| 299 | EDIT | Editas Medicine, Inc. | 123.89M | 2.07% | 2,630,288 | 32.31M |
| 300 | SCPH | scPharmaceuticals Inc. | 122.72M | 0.02% | 210,956 | 36.33M |
| 301 | FATE | Fate Therapeutics, Inc. | 122.05M | 2.40% | 1,131,405 | 13.63M |
| 302 | ALEC | Alector, Inc. | 121.99M | 4.27% | 910,564 | 88.34M |
| 303 | TNXP | Tonix Pharmaceuticals Holding Corp. | 121.81M | 0.53% | 299,697 | 10.09M |
| 304 | ACOG | Alpha Cognition Inc. | 121.44M | 2.03% | 18,735 | - |
| 305 | VIGL | Vigil Neuroscience, Inc. | 120.41M | 6.61% | 99,088 | - |
| 306 | TARA | Protara Therapeutics, Inc. | 120.23M | 0.93% | 201,826 | - |
| 307 | PLX | Protalix BioTherapeutics, Inc. | 119.39M | -11.05% | 4,344,344 | 59.76M |
| 308 | THTX | Theratechnologies Inc. | 119.07M | -0.38% | 351,023 | 88.67M |
| 309 | ENTA | Enanta Pharmaceuticals, Inc. | 119.04M | 5.88% | 56,071 | 66.59M |
| 310 | CHRS | Coherus BioSciences, Inc. | 117.08M | 4.26% | 1,173,560 | 266.96M |
| 311 | RAPT | RAPT Therapeutics, Inc. | 114.96M | 15.33% | 804,605 | - |
| 312 | NMRA | Neumora Therapeutics, Inc. | 114.32M | 6.62% | 763,169 | - |
| 313 | SEER | Seer, Inc. | 113.88M | 3.53% | 146,448 | 14.17M |
| 314 | EXOZ | eXoZymes, Inc. | 113.72M | 4.46% | 35,238 | -700.00 |
| 315 | CLLS | Cellectis S.A. | 112.90M | -2.59% | 17,981 | 49.22M |
| 316 | CCCC | C4 Therapeutics, Inc. | 111.48M | 6.80% | 677,759 | 39.78M |
| 317 | SGMT | Sagimet Biosciences Inc. | 110.43M | 5.21% | 362,278 | - |
| 318 | LCTX | Lineage Cell Therapeutics, Inc. | 108.08M | 7.57% | 555,726 | 9.50M |
| 319 | ATOS | Atossa Therapeutics, Inc. | 108.04M | 2.41% | 412,182 | - |
| 320 | IFRX | InflaRx N.V. | 106.81M | -1.86% | 38,604 | 140.24K |
| 321 | CUPR | Cuprina Holdings (Cayman) Limited | 106.05M | 4.12% | 9,120 | 71.62K |
| 322 | COYA | Coya Therapeutics, Inc. | 104.45M | 3.22% | 19,949 | 3.55M |
| 323 | GNLX | Genelux Corporation | 104.43M | -5.41% | 399,211 | 8.00K |
| 324 | OBIO | Orchestra BioMed Holdings, Inc. | 103.83M | 2.26% | 94,418 | 2.64M |
| 325 | CTNM | Contineum Therapeutics, Inc. | 99.09M | -1.03% | 38,023 | - |
| 326 | MGNX | MacroGenics, Inc. | 99.05M | 9.79% | 276,555 | 149.96M |
| 327 | ENTX | Entera Bio Ltd. | 98.11M | 0.47% | 8,978 | 223.00K |
| 328 | BDTX | Black Diamond Therapeutics, Inc. | 98.05M | 5.49% | 763,182 | - |
| 329 | AGEN | Agenus Inc. | 97.55M | 23.37% | 2,890,790 | 103.46M |
| 330 | IVVD | Invivyd, Inc. | 96.46M | 24.45% | 4,140,371 | 25.38M |
| 331 | KYTX | Kyverna Therapeutics, Inc. | 93.78M | 2.84% | 127,535 | - |
| 332 | IMUX | Immunic, Inc. | 93.54M | -3.35% | 559,785 | - |
| 333 | ORMP | Oramed Pharmaceuticals Inc. | 93.14M | 1.33% | 82,920 | - |
| 334 | ZNTL | Zentalis Pharmaceuticals, Inc. | 92.64M | 4.88% | 476,685 | 67.43M |
| 335 | HLVX | HilleVax, Inc. | 92.51M | -1.84% | 33,641 | - |
| 336 | NAUT | Nautilus Biotechnology, Inc. | 92.49M | 4.74% | 100,242 | - |
| 337 | PLRX | Pliant Therapeutics, Inc. | 92.39M | 6.74% | 525,954 | - |
| 338 | ASMB | Assembly Biosciences, Inc. | 91.92M | 0.08% | 4,866 | 32.15M |
| 339 | VTYX | Ventyx Biosciences, Inc. | 91.80M | 4.03% | 1,089,481 | - |
| 340 | VXRT | Vaxart, Inc. | 91.61M | -4.22% | 1,333,478 | 28.70M |
| 341 | TIL | Instil Bio, Inc. | 89.93M | 4.16% | 62,872 | - |
| 342 | SAVA | Cassava Sciences, Inc. | 89.13M | 4.24% | 774,897 | - |
| 343 | LXEO | Lexeo Therapeutics, Inc. | 88.97M | -0.37% | 720,003 | - |
| 344 | GALT | Galectin Therapeutics Inc. | 88.02M | 0.96% | 155,212 | - |
| 345 | ELTX | Elicio Therapeutics, Inc. | 86.55M | -1.09% | 4,547 | - |
| 346 | SNTI | Senti Biosciences, Inc. | 86.46M | 1.99% | 11,284 | - |
| 347 | XBIT | XBiotech Inc. | 86.28M | 2.17% | 41,979 | - |
| 348 | CLYM | Climb Bio, Inc. | 85.82M | 6.72% | 49,083 | - |
| 349 | ACHV | Achieve Life Sciences, Inc. | 85.50M | 4.89% | 78,791 | - |
| 350 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 85.41M | 8.22% | 99,692 | - |
| 351 | ANIX | Anixa Biosciences, Inc. | 84.51M | 0.57% | 61,935 | - |
| 352 | GUTS | Fractyl Health, Inc. | 83.26M | 4.94% | 128,203 | 93.00K |
| 353 | CBUS | Cibus, Inc. | 82.52M | 11.89% | 113,950 | 4.75M |
| 354 | ADAG | Adagene Inc. | 82.44M | 9.37% | 23,583 | 103.20K |
| 355 | CSBR | Champions Oncology, Inc. | 81.83M | -4.02% | 15,100 | 58.59M |
| 356 | MIST | Milestone Pharmaceuticals Inc. | 78.85M | 7.21% | 673,054 | - |
| 357 | ADAP | Adaptimmune Therapeutics plc | 78.44M | 1.57% | 680,963 | 178.03M |
| 358 | GNTA | Genenta Science S.p.A. | 77.73M | -2.07% | 192 | - |
| 359 | WHWK | Whitehawk Therapeutics, Inc. | 77.19M | -2.94% | 59,444 | 27.78M |
| 360 | ZURA | Zura Bio Limited | 77.03M | 2.89% | 135,116 | - |
| 361 | CRVO | CervoMed Inc. | 77.02M | 4.24% | 209,156 | 9.31M |
| 362 | VERU | Veru Inc. | 76.97M | 4.29% | 1,003,756 | 16.89M |
| 363 | TCRX | TScan Therapeutics, Inc. | 76.96M | 7.08% | 182,470 | 4.42M |
| 364 | INZY | Inozyme Pharma, Inc. | 76.51M | 3.04% | 524,868 | - |
| 365 | CRBU | Caribou Biosciences, Inc. | 75.56M | 4.92% | 576,068 | 9.92M |
| 366 | EPIX | ESSA Pharma Inc. | 75.02M | -1.74% | 91,760 | - |
| 367 | IMAB | I-Mab | 74.95M | 4.50% | 109,846 | 569.46K |
| 368 | TELO | Telomir Pharmaceuticals, Inc. | 74.70M | 0.80% | 102,604 | - |
| 369 | STRO | Sutro Biopharma, Inc. | 73.57M | -0.06% | 1,330,602 | 66.43M |
| 370 | JSPR | Jasper Therapeutics, Inc. | 72.26M | 6.42% | 86,808 | - |
| 371 | IGMS | IGM Biosciences, Inc. | 71.73M | 6.19% | 114,725 | 2.68M |
| 372 | XCUR | Exicure, Inc. | 71.20M | -1.49% | 7,607 | 500.00K |
| 373 | MNOV | MediciNova, Inc. | 71.12M | -1.36% | 5,914 | - |
| 374 | CNTX | Context Therapeutics Inc. | 70.81M | 1.08% | 91,102 | - |
| 375 | ATHE | Alterity Therapeutics Limited | 70.29M | -7.29% | 32,823 | 2.30M |
| 376 | INO | Inovio Pharmaceuticals, Inc. | 70.05M | 6.11% | 468,818 | 217.76K |
| 377 | PYXS | Pyxis Oncology, Inc. | 70.00M | 5.61% | 312,888 | 16.15M |
| 378 | ANL | Adlai Nortye Ltd. | 69.74M | 2.16% | 3,922 | 1.94M |
| 379 | SRZN | Surrozen, Inc. | 69.66M | -1.80% | 10,307 | 11.64M |
| 380 | CLSD | Clearside Biomedical, Inc. | 68.78M | 3.63% | 108,239 | 1.66M |
| 381 | MCRB | Seres Therapeutics, Inc. | 68.48M | 11.34% | 75,034 | - |
| 382 | TNYA | Tenaya Therapeutics, Inc. | 68.29M | 1.43% | 2,051,849 | - |
| 383 | VTVT | vTv Therapeutics Inc. | 68.18M | 2.77% | 967 | 1.02M |
| 384 | VTGN | Vistagen Therapeutics, Inc. | 67.54M | 4.46% | 24,739 | 698.00K |
| 385 | UNCY | Unicycive Therapeutics, Inc. | 67.43M | 2.42% | 613,152 | - |
| 386 | BYSI | BeyondSpring Inc. | 66.52M | -1.79% | 12,661 | 1.88M |
| 387 | BMEA | Biomea Fusion, Inc. | 66.50M | 8.59% | 325,975 | - |
| 388 | KLRS | Kalaris Therapeutics, Inc. | 66.21M | 1.72% | 15,160 | - |
| 389 | NTRB | Nutriband Inc. | 65.40M | 2.80% | 14,247 | 2.14M |
| 390 | IOBT | IO Biotech, Inc. | 65.29M | -0.90% | 81,933 | - |
| 391 | CABA | Cabaletta Bio, Inc. | 65.20M | 7.98% | 596,892 | - |
| 392 | APLT | Applied Therapeutics, Inc. | 64.63M | 14.21% | 1,824,717 | 455.00K |
| 393 | ABOS | Acumen Pharmaceuticals, Inc. | 63.60M | 7.13% | 116,154 | - |
| 394 | SKYE | Skye Bioscience, Inc. | 62.90M | 12.15% | 139,779 | - |
| 395 | ANRO | Alto Neuroscience, Inc. | 62.81M | 4.50% | 57,640 | - |
| 396 | VANI | Vivani Medical, Inc. | 61.02M | -0.96% | 33,881 | - |
| 397 | PDSB | PDS Biotechnology Corporation | 59.92M | 10.00% | 249,440 | - |
| 398 | SER | Serina Therapeutics, Inc. | 59.41M | 6.24% | 2,308 | 51.00K |
| 399 | MAIA | MAIA Biotechnology, Inc. | 58.58M | -2.94% | 201,111 | - |
| 400 | MGX | Metagenomi, Inc. | 58.32M | 3.31% | 211,978 | 52.30M |
| 401 | ADVM | Adverum Biotechnologies, Inc. | 58.28M | -0.71% | 422,909 | 1.00M |
| 402 | RPTX | Repare Therapeutics Inc. | 58.24M | 0.74% | 228,310 | 53.48M |
| 403 | IMMX | Immix Biopharma, Inc. | 57.94M | - | 37,278 | - |
| 404 | CUE | Cue Biopharma, Inc. | 57.35M | -2.39% | 144,295 | 9.29M |
| 405 | IKNA | Ikena Oncology, Inc. | 56.46M | 3.54% | 27,880 | - |
| 406 | ACET | Adicet Bio, Inc. | 56.21M | 11.46% | 1,069,796 | - |
| 407 | RENB | Renovaro Inc. | 55.61M | 1.39% | 962,639 | - |
| 408 | DTIL | Precision BioSciences, Inc. | 54.61M | 1.56% | 70,695 | 68.70M |
| 409 | GANX | Gain Therapeutics, Inc. | 53.91M | - | 183,595 | - |
| 410 | ARTV | Artiva Biotherapeutics, Inc. | 52.87M | 4.33% | 93,860 | 251.00K |
| 411 | OTLK | Outlook Therapeutics, Inc. | 51.54M | 3.27% | 578,324 | - |
| 412 | KPTI | Karyopharm Therapeutics Inc. | 50.74M | -1.50% | 39,502 | 145.24M |
| 413 | ARMP | Armata Pharmaceuticals, Inc. | 49.57M | 6.20% | 5,843 | 5.17M |
| 414 | PEPG | PepGen Inc. | 49.41M | 0.67% | 96,006 | - |
| 415 | CYCC | Cyclacel Pharmaceuticals, Inc. | 48.98M | -6.77% | 124,852 | 43.00K |
| 416 | PRLD | Prelude Therapeutics Incorporated | 48.96M | 11.04% | 44,881 | 7.00M |
| 417 | FBIO | Fortress Biotech, Inc. | 48.73M | -2.37% | 105,596 | 57.68M |
| 418 | ATNM | Actinium Pharmaceuticals, Inc. | 48.04M | 4.05% | 162,105 | 81.00K |
| 419 | STTK | Shattuck Labs, Inc. | 47.32M | 4.23% | 14,833 | 4.61M |
| 420 | OKYO | OKYO Pharma Limited | 46.56M | -5.39% | 23,749 | - |
| 421 | VRCA | Verrica Pharmaceuticals Inc. | 46.50M | 14.30% | 145,466 | 7.57M |
| 422 | ICCC | ImmuCell Corporation | 46.26M | 1.50% | 22,878 | 26.49M |
| 423 | IPSC | Century Therapeutics, Inc. | 45.78M | -1.06% | 185,604 | 6.59M |
| 424 | PMVP | PMV Pharmaceuticals, Inc. | 45.25M | -1.28% | 111,505 | - |
| 425 | MURA | Mural Oncology plc | 44.97M | -0.76% | 288,470 | - |
| 426 | MRSN | Mersana Therapeutics, Inc. | 44.52M | 12.01% | 2,125,657 | 40.50M |
| 427 | KRON | Kronos Bio, Inc. | 44.51M | 1.16% | 2,492,578 | 9.19M |
| 428 | QNCX | Quince Therapeutics, Inc. | 44.44M | -0.98% | 152,720 | - |
| 429 | LTRN | Lantern Pharma Inc. | 44.22M | 3.02% | 34,372 | - |
| 430 | ONCY | Oncolytics Biotech Inc. | 44.11M | 3.41% | 224,919 | - |
| 431 | IRD | Opus Genetics, Inc. | 43.21M | 0.34% | 73,605 | 10.99M |
| 432 | CNTB | Connect Biopharma Holdings Limited | 43.17M | -3.68% | 70,817 | 26.03M |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 42.37M | 18.07% | 428,039 | 1.14M |
| 434 | FBRX | Forte Biosciences, Inc. | 41.99M | - | 21,720 | - |
| 435 | ATRA | Atara Biotherapeutics, Inc. | 41.95M | -1.51% | 25,557 | 128.94M |
| 436 | AVTX | Avalo Therapeutics, Inc. | 41.94M | -3.20% | 52,514 | 441.00K |
| 437 | CAMP | Camp4 Therapeutics Corporation | 41.94M | -2.35% | 110,024 | 652.00K |
| 438 | IMRX | Immuneering Corporation | 41.74M | 1.75% | 337,728 | - |
| 439 | PLUR | Pluri Inc. | 41.64M | -7.13% | 47,476 | 678.00K |
| 440 | AKTX | Akari Therapeutics, Plc | 40.43M | 11.10% | 21,349 | - |
| 441 | ANEB | Anebulo Pharmaceuticals, Inc. | 39.89M | -6.63% | 42,913 | - |
| 442 | RNTX | Rein Therapeutics Inc. | 39.59M | 2.27% | 120,923 | - |
| 443 | ACRV | Acrivon Therapeutics, Inc. | 39.04M | 7.33% | 618,592 | - |
| 444 | RNXT | RenovoRx, Inc. | 38.21M | -1.38% | 57,235 | 43.00K |
| 445 | GRCE | Grace Therapeutics, Inc. | 37.86M | 1.47% | 5,945 | - |
| 446 | OSTX | OS Therapies Incorporated | 37.05M | -12.31% | 448,520 | - |
| 447 | RANI | Rani Therapeutics Holdings, Inc. | 36.96M | -11.92% | 680,108 | 1.03M |
| 448 | XLO | Xilio Therapeutics, Inc. | 36.75M | -0.01% | 368,335 | 9.27M |
| 449 | MLEC | Moolec Science SA | 36.10M | -1.14% | 34,413 | 7.83M |
| 450 | ANTX | AN2 Therapeutics, Inc. | 36.01M | -0.30% | 19,163 | - |
| 451 | ITRM | Iterum Therapeutics plc | 35.96M | 1.96% | 385,582 | - |
| 452 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 35.90M | -6.29% | 545,133 | - |
| 453 | SPRO | Spero Therapeutics, Inc. | 35.59M | 2.69% | 84,603 | 47.98M |
| 454 | ESLA | Estrella Immunopharma, Inc. | 35.44M | -4.85% | 30,409 | - |
| 455 | CELU | Celularity Inc. | 34.74M | -7.49% | 40,395 | 54.22M |
| 456 | NRXP | NRx Pharmaceuticals, Inc. | 34.68M | 0.49% | 22,425 | - |
| 457 | BRNS | Barinthus Biotherapeutics plc | 33.97M | -2.88% | 58,698 | 14.97M |
| 458 | BLUE | bluebird bio, Inc. | 33.92M | -1.00% | 351,276 | 83.81M |
| 459 | LVTX | LAVA Therapeutics N.V. | 33.67M | 2.40% | 20,112 | 11.98M |
| 460 | BOLD | Boundless Bio, Inc. | 33.13M | 2.78% | 19,324 | - |
| 461 | COEP | Coeptis Therapeutics Holdings, Inc. | 33.04M | 3.37% | 58,299 | - |
| 462 | DYAI | Dyadic International, Inc. | 32.99M | 2.45% | 17,895 | 3.50M |
| 463 | ALGS | Aligos Therapeutics, Inc. | 32.96M | 20.31% | 201,547 | 3.27M |
| 464 | FBLG | FibroBiologics, Inc. | 32.18M | 1.25% | 110,987 | - |
| 465 | KZR | Kezar Life Sciences, Inc. | 31.78M | 3.08% | 6,761 | - |
| 466 | RADX | Radiopharm Theranostics Limited | 31.45M | -2.34% | 22,287 | 204.61K |
| 467 | FGEN | FibroGen, Inc. | 31.01M | -0.36% | 566,352 | 29.62M |
| 468 | ANVS | Annovis Bio, Inc. | 29.81M | - | 160,962 | - |
| 469 | ALLK | Allakos Inc. | 29.57M | -0.40% | 395,749 | - |
| 470 | PYPD | PolyPid Ltd. | 29.54M | 4.64% | 20,544 | - |
| 471 | CASI | CASI Pharmaceuticals, Inc. | 29.13M | -0.29% | 10,176 | 28.54M |
| 472 | INKT | MiNK Therapeutics, Inc. | 28.68M | 2.84% | 9,354 | - |
| 473 | CALC | CalciMedica, Inc. | 26.83M | -0.50% | 13,440 | - |
| 474 | GDTC | CytoMed Therapeutics Limited | 26.77M | 4.50% | 2,196 | 368.84K |
| 475 | NRSN | NeuroSense Therapeutics Ltd. | 26.39M | 5.38% | 113,826 | - |
| 476 | GBIO | Generation Bio Co. | 26.37M | 9.28% | 814,135 | 24.56M |
| 477 | OKUR | OnKure Therapeutics, Inc. | 26.08M | 1.04% | 134,232 | - |
| 478 | DARE | Daré Bioscience, Inc. | 25.49M | -1.03% | 9,018 | 9.78K |
| 479 | CVKD | Cadrenal Therapeutics, Inc. | 25.36M | -6.64% | 39,962 | - |
| 480 | BCAB | BioAtla, Inc. | 25.09M | -0.02% | 231,966 | 11.00M |
| 481 | OSRH | OSR Holdings, Inc. | 25.06M | 4.00% | 42,321 | - |
| 482 | IGC | IGC Pharma, Inc. | 24.06M | 1.36% | 119,989 | 1.24M |
| 483 | CMMB | Chemomab Therapeutics Ltd. | 23.76M | - | 27,359 | - |
| 484 | ENLV | Enlivex Therapeutics Ltd. | 23.65M | -1.96% | 22,634 | - |
| 485 | TPST | Tempest Therapeutics, Inc. | 23.62M | 4.01% | 34,334 | - |
| 486 | ALXO | ALX Oncology Holdings Inc. | 23.16M | 2.63% | 382,581 | - |
| 487 | LSB | LakeShore Biopharma Co., Ltd | 22.83M | 4.96% | 37,012 | 79.42M |
| 488 | PULM | Pulmatrix, Inc. | 22.79M | 0.65% | 20,333 | 7.81M |
| 489 | ADVB | Advanced Biomed Inc. | 22.72M | 10.65% | 150,081 | - |
| 490 | KALA | KALA BIO, Inc. | 22.60M | 2.40% | 30,715 | - |
| 491 | ABVC | ABVC BioPharma, Inc. | 22.30M | 14.88% | 346,506 | 508.38K |
| 492 | LGVN | Longeveron Inc. | 21.65M | 8.21% | 98,696 | 2.23M |
| 493 | APUS | Apimeds Pharmaceuticals US, Inc. | 21.64M | -15.00% | 314,113 | - |
| 494 | CVM | CEL-SCI Corporation | 21.27M | 2.43% | 547,068 | - |
| 495 | VOR | Vor Biopharma Inc. | 21.22M | 12.36% | 5,611,815 | - |
| 496 | LEXX | Lexaria Bioscience Corp. | 21.04M | 0.01% | 96,215 | 525.92K |
| 497 | BIVI | BioVie Inc. | 21.04M | 1.79% | 497,205 | - |
| 498 | SLGL | Sol-Gel Technologies Ltd. | 20.92M | -4.33% | 22,913 | 11.54M |
| 499 | OVID | Ovid Therapeutics Inc. | 20.82M | 1.00% | 234,207 | 566.00K |
| 500 | IPA | ImmunoPrecise Antibodies Ltd. | 20.75M | 1.02% | 267,004 | 16.58M |
| 501 | ELEV | Elevation Oncology, Inc. | 20.73M | 2.04% | 511,582 | - |
| 502 | JUNS | Jupiter Neurosciences, Inc. | 20.52M | -0.03% | 27,720 | - |
| 503 | CGTX | Cognition Therapeutics, Inc. | 20.20M | 8.27% | 1,970,604 | - |
| 504 | QTTB | Q32 Bio Inc. | 20.15M | 6.57% | 72,271 | - |
| 505 | NNVC | NanoViricides, Inc. | 20.10M | -2.65% | 62,670 | - |
| 506 | CRIS | Curis, Inc. | 19.56M | -1.06% | 99,495 | 11.20M |
| 507 | CLGN | CollPlant Biotechnologies Ltd. | 19.37M | -7.08% | 11,477 | 515.00K |
| 508 | XFOR | X4 Pharmaceuticals, Inc. | 18.87M | -3.26% | 131,369 | 31.36M |
| 509 | SABS | SAB Biotherapeutics, Inc. | 18.76M | 12.85% | 129,489 | 377.84K |
| 510 | LSTA | Lisata Therapeutics, Inc. | 18.71M | 5.94% | 6,777 | 1.00M |
| 511 | PASG | Passage Bio, Inc. | 18.51M | -9.54% | 336,744 | - |
| 512 | VYNE | VYNE Therapeutics Inc. | 18.24M | -5.38% | 214,823 | 605.00K |
| 513 | BCTX | BriaCell Therapeutics Corp. | 17.79M | 0.32% | 105,233 | - |
| 514 | ALLR | Allarity Therapeutics, Inc. | 17.70M | -0.95% | 571,894 | - |
| 515 | PMN | ProMIS Neurosciences, Inc. | 16.52M | 0.68% | 177,417 | - |
| 516 | CLDI | Calidi Biotherapeutics, Inc. | 16.33M | -2.03% | 141,991 | - |
| 517 | GLYC | GlycoMimetics, Inc. | 16.26M | 4.91% | 427,912 | - |
| 518 | NRXS | NeurAxis, Inc. | 16.24M | 12.50% | 15,865 | 2.93M |
| 519 | HOOK | HOOKIPA Pharma Inc. | 15.93M | -2.31% | 94,365 | 43.95M |
| 520 | ASBP | Aspire Biopharma Holdings, Inc. | 15.58M | -6.03% | 110,642 | - |
| 521 | LPTX | Leap Therapeutics, Inc. | 15.46M | 11.88% | 286,414 | - |
| 522 | COCP | Cocrystal Pharma, Inc. | 15.40M | -0.39% | 13,296 | - |
| 523 | CANF | Can-Fite BioPharma Ltd. | 15.39M | -0.90% | 54,920 | 674.00K |
| 524 | UBX | Unity Biotechnology, Inc. | 15.29M | -2.82% | 140,212 | - |
| 525 | LPCN | Lipocine Inc. | 15.25M | -12.98% | 130,563 | 3.67M |
| 526 | CING | Cingulate Inc. | 15.07M | -0.25% | 34,552 | - |
| 527 | BCDA | BioCardia, Inc. | 14.37M | -0.88% | 19,254 | 58.00K |
| 528 | MBRX | Moleculin Biotech, Inc. | 14.35M | -2.38% | 2,256,749 | - |
| 529 | EDSA | Edesa Biotech, Inc. | 14.22M | -0.95% | 11,351 | - |
| 530 | EQ | Equillium, Inc. | 13.93M | -0.13% | 35,590 | 41.10M |
| 531 | MEIP | MEI Pharma, Inc. | 13.93M | 2.20% | 1,709 | - |
| 532 | BRTX | BioRestorative Therapies, Inc. | 13.81M | 2.22% | 17,544 | 401.00K |
| 533 | BOLT | Bolt Biotherapeutics, Inc. | 13.50M | -1.65% | 39,706 | 7.69M |
| 534 | SYBX | Synlogic, Inc. | 13.45M | 2.68% | 22,397 | 8.00K |
| 535 | RLMD | Relmada Therapeutics, Inc. | 13.29M | -4.58% | 609,456 | - |
| 536 | PHGE | BiomX Inc. | 13.23M | 2.73% | 35,867 | - |
| 537 | IBIO | iBio, Inc. | 13.21M | 3.42% | 730,756 | 375.00K |
| 538 | GOVX | GeoVax Labs, Inc. | 13.00M | 1.29% | 280,311 | 5.59M |
| 539 | RLYB | Rallybio Corporation | 12.87M | 5.53% | 20,548 | 848.00K |
| 540 | INAB | IN8bio, Inc. | 12.71M | -0.64% | 874,791 | - |
| 541 | PRTG | Portage Biotech Inc. | 12.34M | -8.29% | 72,810 | - |
| 542 | MRKR | Marker Therapeutics, Inc. | 12.32M | -0.86% | 19,558 | 6.59M |
| 543 | HOTH | Hoth Therapeutics, Inc. | 12.25M | -2.37% | 1,093,463 | - |
| 544 | AFMD | Affimed N.V. | 12.03M | 7.14% | 51,523 | 6.29M |
| 545 | BLRX | BioLineRx Ltd. | 11.98M | -3.47% | 13,402 | 28.94M |
| 546 | NXTC | NextCure, Inc. | 11.76M | -5.83% | 71,574 | - |
| 547 | CLRB | Cellectar Biosciences, Inc. | 11.76M | 3.15% | 183,679 | - |
| 548 | IMNN | Imunon, Inc. | 11.75M | 1.25% | 53,756 | - |
| 549 | XTLB | XTL Biopharmaceuticals Ltd. | 11.45M | 5.56% | 6,252 | 451.00K |
| 550 | NERV | Minerva Neurosciences, Inc. | 11.33M | 0.62% | 3,170 | - |
| 551 | CSCI | COSCIENS Biopharma Inc. | 11.17M | -3.10% | 7,182 | 9.59M |
| 552 | ICU | SeaStar Medical Holding Corporation | 11.12M | 2.41% | 120,392 | 135.00K |
| 553 | IMRN | Immuron Limited | 10.80M | 5.79% | 30,911 | 4.05M |
| 554 | PSTV | Plus Therapeutics, Inc. | 10.80M | -3.77% | 1,327,371 | 5.82M |
| 555 | ERNA | Ernexa Therapeutics Inc. | 10.72M | 2.78% | 70,701 | 535.00K |
| 556 | ATHA | Athira Pharma, Inc. | 10.52M | 5.98% | 112,544 | - |
| 557 | KAPA | Kairos Pharma, Ltd. | 10.35M | -8.97% | 193,888 | - |
| 558 | ABP | Abpro Holdings, Inc. | 9.73M | -5.00% | 252,520 | 183.00K |
| 559 | KPRX | Kiora Pharmaceuticals, Inc. | 9.57M | -1.85% | 10,040 | 20.00K |
| 560 | EVAX | Evaxion Biotech A/S | 9.47M | 0.67% | 44,151 | 3.34M |
| 561 | DWTX | Dogwood Therapeutics, Inc. | 9.27M | 6.36% | 174,319 | - |
| 562 | APRE | Aprea Therapeutics, Inc. | 9.06M | 1.85% | 12,480 | 1.50M |
| 563 | NEUP | Neuphoria Therapeutics Inc. | 8.79M | -0.20% | 14,913 | 662.72K |
| 564 | SNSE | Sensei Biotherapeutics, Inc. | 8.72M | -3.94% | 237,287 | - |
| 565 | ACXP | Acurx Pharmaceuticals, Inc. | 8.67M | 7.67% | 569,384 | - |
| 566 | PHIO | Phio Pharmaceuticals Corp. | 8.55M | 1.70% | 180,225 | - |
| 567 | INTS | Intensity Therapeutics, Inc. | 8.27M | 1.11% | 77,002 | - |
| 568 | SLXN | Silexion Therapeutics Corp | 8.25M | -0.48% | 172,720 | - |
| 569 | BTAI | BioXcel Therapeutics, Inc. | 8.15M | -2.61% | 130,043 | 1.85M |
| 570 | RNAZ | TransCode Therapeutics, Inc. | 8.13M | 1.96% | 1,600,944 | - |
| 571 | CYCN | Cyclerion Therapeutics, Inc. | 8.01M | -4.07% | 22,947 | 2.08M |
| 572 | CARM | Carisma Therapeutics, Inc. | 7.96M | 0.05% | 291,107 | 19.63M |
| 573 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.84M | -18.75% | 3,487,309 | 34.89K |
| 574 | BCLI | Brainstorm Cell Therapeutics Inc. | 7.83M | 1.69% | 87,078 | - |
| 575 | TSBX | Turnstone Biologics Corp. | 7.75M | -1.41% | 99,825 | - |
| 576 | PMCB | PharmaCyte Biotech, Inc. | 7.56M | -0.90% | 9,326 | - |
| 577 | EVGN | Evogene Ltd. | 7.48M | 1.55% | 15,137 | 8.51M |
| 578 | CTXR | Citius Pharmaceuticals, Inc. | 7.25M | -1.68% | 95,529 | - |
| 579 | TRAW | Traws Pharma, Inc. | 6.93M | 2.63% | 36,030 | 226.00K |
| 580 | ADXN | Addex Therapeutics Ltd | 6.87M | 3.46% | 1,069 | 701.26K |
| 581 | IBO | Impact BioMedical Inc. | 6.86M | 3.26% | 851,672 | - |
| 582 | GNPX | Genprex, Inc. | 6.64M | -3.68% | 946,063 | - |
| 583 | CHRO | Channel Therapeutics Corporation | 6.45M | -3.95% | 143,201 | - |
| 584 | APM | Aptorum Group Limited | 6.32M | 2.76% | 19,911 | - |
| 585 | PPBT | Purple Biotech Ltd | 6.29M | 0.68% | 13,082 | - |
| 586 | LIPO | Lipella Pharmaceuticals Inc. | 6.24M | 2.08% | 7,532 | 536.36K |
| 587 | LYRA | Lyra Therapeutics, Inc. | 6.13M | -5.80% | 1,431,652 | 1.19M |
| 588 | HCWB | HCW Biologics Inc. | 6.10M | -12.14% | 40,733 | 2.57M |
| 589 | SNGX | Soligenix, Inc. | 6.09M | -2.53% | 6,357 | 2.34K |
| 590 | MTVA | MetaVia Inc. | 6.06M | -3.98% | 149,015 | - |
| 591 | APLM | Apollomics, Inc. | 5.95M | -5.11% | 1,470 | 198.00K |
| 592 | GTBP | GT Biopharma, Inc. | 5.83M | 1.32% | 2,768 | - |
| 593 | INDP | Indaptus Therapeutics, Inc. | 5.77M | -0.15% | 111,178 | - |
| 594 | ATNF | 180 Life Sciences Corp. | 5.76M | 1.83% | 43,479 | - |
| 595 | JAGX | Jaguar Health, Inc. | 5.26M | -8.23% | 102,902 | 11.69M |
| 596 | KTTA | Pasithea Therapeutics Corp. | 5.26M | 4.57% | 935,000 | - |
| 597 | AEON | AEON Biopharma, Inc. | 5.05M | 1.35% | 196,070 | - |
| 598 | CMND | Clearmind Medicine Inc. | 5.03M | 1.40% | 57,418 | - |
| 599 | TTNP | Titan Pharmaceuticals, Inc. | 4.98M | 7.07% | 140,037 | - |
| 600 | VRAX | Virax Biolabs Group Limited | 4.65M | 1.90% | 17,434 | 84.87K |
| 601 | XBIO | Xenetic Biosciences, Inc. | 4.64M | -1.63% | 10,544 | 2.50M |
| 602 | TCRT | Alaunos Therapeutics, Inc. | 4.61M | 1.05% | 5,423 | 10.00K |
| 603 | CDT | Conduit Pharmaceuticals Inc. | 4.54M | - | 436,960 | - |
| 604 | SILO | Silo Pharma, Inc. | 4.48M | 22.71% | 460,443 | 72.10K |
| 605 | KLTO | Klotho Neurosciences, Inc. | 4.34M | -8.43% | 170,077 | - |
| 606 | DRMA | Dermata Therapeutics, Inc. | 4.24M | -3.75% | 141,351 | - |
| 607 | AZTR | Azitra, Inc. | 4.22M | -4.58% | 567,188 | 7.50K |
| 608 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 4.05M | 3.13% | 21,333 | 1.00M |
| 609 | ADIL | Adial Pharmaceuticals, Inc. | 4.04M | 2.18% | 161,970 | - |
| 610 | KZIA | Kazia Therapeutics Limited | 3.98M | -1.66% | 9,264 | 1.66M |
| 611 | SPRC | SciSparc Ltd. | 3.93M | 5.52% | 675,281 | 1.31M |
| 612 | XRTX | XORTX Therapeutics Inc. | 3.89M | 1.96% | 4,035 | - |
| 613 | ALZN | Alzamend Neuro, Inc. | 3.87M | -10.78% | 122,586 | - |
| 614 | OGEN | Oragenics, Inc. | 3.84M | 6.17% | 279,034 | - |
| 615 | CNSP | CNS Pharmaceuticals, Inc. | 3.74M | 11.39% | 311,941 | - |
| 616 | MBIO | Mustang Bio, Inc. | 3.74M | -2.92% | 102,553 | - |
| 617 | QNRX | Quoin Pharmaceuticals, Ltd. | 3.69M | 1.45% | 6,333 | - |
| 618 | GLTO | Galecto, Inc. | 3.68M | 1.28% | 15,625 | - |
| 619 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.51M | -0.42% | 15,465 | 681.35K |
| 620 | LIXT | Lixte Biotechnology Holdings, Inc. | 3.43M | 5.19% | 5,078 | - |
| 621 | HEPA | Hepion Pharmaceuticals, Inc. | 3.43M | -20.30% | 1,925,149 | - |
| 622 | VIVS | VivoSim Labs, Inc. | 3.42M | 1.05% | 70,492 | 122.00K |
| 623 | ENVB | Enveric Biosciences, Inc. | 3.39M | 7.01% | 51,763 | - |
| 624 | SNPX | Synaptogenix, Inc. | 3.38M | 1.05% | 6,696 | - |
| 625 | ARTL | Artelo Biosciences, Inc. | 3.35M | - | 5,557 | - |
| 626 | CERO | CERo Therapeutics Holdings, Inc. | 3.30M | -5.62% | 495,074 | - |
| 627 | MTNB | Matinas BioPharma Holdings, Inc. | 3.28M | -8.43% | 211,331 | - |
| 628 | EYEN | Eyenovia, Inc. | 3.28M | 7.41% | 73,595 | 57.34K |
| 629 | BDRX | Biodexa Pharmaceuticals Plc | 3.28M | -9.22% | 1,822,299 | 104.90K |
| 630 | THAR | Tharimmune, Inc. | 3.27M | 2.65% | 38,908 | - |
| 631 | WINT | Windtree Therapeutics, Inc. | 3.22M | 6.40% | 209,514 | - |
| 632 | PALI | Palisade Bio, Inc. | 3.22M | -2.86% | 51,822 | - |
| 633 | NBY | NovaBay Pharmaceuticals, Inc. | 3.20M | -2.48% | 32,921 | 9.78M |
| 634 | REVB | Revelation Biosciences, Inc. | 3.02M | 5.09% | 25,523 | - |
| 635 | ENSC | Ensysce Biosciences, Inc. | 2.99M | -1.84% | 120,104 | 5.21M |
| 636 | GLMD | Galmed Pharmaceuticals Ltd. | 2.87M | 2.40% | 430,943 | - |
| 637 | NLSP | NLS Pharmaceutics AG | 2.69M | 1.22% | 20,839 | - |
| 638 | QLGN | Qualigen Therapeutics, Inc. | 2.69M | 1.67% | 32,904 | - |
| 639 | SCNI | Scinai Immunotherapeutics Ltd. | 2.47M | 2.71% | 5,142 | 658.00K |
| 640 | PLRZ | Polyrizon Ltd. | 2.38M | -6.59% | 3,994,644 | - |
| 641 | PBM | Psyence Biomedical Ltd. | 2.19M | -0.27% | 102,077 | - |
| 642 | ADTX | Aditxt, Inc. | 2.03M | 1.16% | 68,622 | 133.99K |
| 643 | ENTO | Entero Therapeutics, Inc. | 1.95M | -2.51% | 43,187 | - |
| 644 | TNFA | TNF Pharmaceuticals, Inc. | 1.94M | 0.58% | 1,431,508 | - |
| 645 | ZVSA | ZyVersa Therapeutics, Inc. | 1.92M | 0.53% | 484,117 | - |
| 646 | ELAB | PMGC Holdings Inc. | 1.71M | 1.46% | 63,612 | 2.45M |
| 647 | PTIX | Protagenic Therapeutics, Inc. | 1.60M | -4.18% | 61,750 | - |
| 648 | TOVX | Theriva Biologics, Inc. | 1.45M | -1.83% | 577,234 | - |
| 649 | SLRX | Salarius Pharmaceuticals, Inc. | 1.40M | 3.75% | 27,040 | - |
| 650 | PCSA | Processa Pharmaceuticals, Inc. | 1.24M | -1.26% | 864,333 | - |
| 651 | APVO | Aptevo Therapeutics Inc. | 1.10M | - | 580,725 | - |
| 652 | GRI | GRI Bio, Inc. | 809.05K | 4.76% | 89,192 | - |
| 653 | ONCO | Onconetix, Inc. | 588.93K | -1.39% | 7,361,688 | 1.87M |
| 654 | NCNA | NuCana plc | 242.28K | -4.76% | 60,875,925 | - |